Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
The Older Adult Hematologic Malignancy (OHM) Program team includes oncologists, nurse practitioners, and physician assistants with many years of experience treating patients with blood cancers. Our team also includes social workers and geriatricians who
have a special understanding of the issues affecting older adults with blood cancers and their families. Finally, we work with population, clinical, and basic scientists for the research component of the program.
Gregory A. Abel, MD, MPH, Director
Jane Ann Driver, MD, MPH, Co-Director
Leukemia and Myelodysplastic Syndrome:
Richard M. Stone, MD
Caron A. Jacobson, MD
Jacob Laubach, MD, MPP
New Patient Appointments
Gregory A. Abel, MD, MPH Benjamin L. Ebert, MD, PhD J. Michael Gaziano, MD, MPH
Andrew Lane, MD, PhD Jerome Ritz, MD Robert J. Soiffer, MD Naeem Tahir, MD Catherine J. Wu, MD